Date Published
September 2, 2021
Updated For
ALS PCS Version 5.2
#SWORBHPTips
New to the 2020 AHA guidelines is the preference for IV medication administration during ACLS, over IO administration.
A recent systematic review found better clinical outcome in patients that received ACLS drug administration via IV vs IO.
Consistent with the current ALS-PCS treatment, they state IO access is acceptable if IV access is unavailable.
For more great evidence based recommendations, check out your 2021 MCME Precourse module on the AHA Guidelines Update!
Categories
Additional Resources:
No additional resources available for this #SWORBHPTip.
